carnitine has been researched along with paclitaxel in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A | 1 |
| Du, Y; Fu, Q; Ganapathy, V; He, Z; Kou, L; Luo, Q; Sun, J; Sun, M; Wang, G; Wang, J; Wu, C; Yao, Q | 1 |
| Feng, J; Huang, L; Mo, H; Wu, W; Yang, T; Zhang, Q; Zhang, W | 1 |
| Chang, LC; Huang, JW; Kuo, CH; Kuo, HC; Shih, JY; Tsai, TW | 1 |
| Gao, X; Guan, W; Li, X; Liu, H; Wang, C; Wang, F; Xu, G; Xu, X; Yuan, J; Zhang, J | 1 |
1 trial(s) available for carnitine and paclitaxel
| Article | Year |
|---|---|
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine | 2007 |
6 other study(ies) available for carnitine and paclitaxel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs.
Topics: Administration, Oral; Biological Availability; Caco-2 Cells; Carnitine; Endocytosis; Humans; Intestinal Absorption; Ions; Lactic Acid; Lymphatic System; Molecular Docking Simulation; Nanoparticles; Paclitaxel; Photoelectron Spectroscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Messenger; Sodium; Solute Carrier Family 22 Member 5 | 2017 |
l-Carnitine conjugated chitosan-stearic acid polymeric micelles for improving the oral bioavailability of paclitaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Caco-2 Cells; Carnitine; Chitosan; Drug Carriers; Drug Liberation; Female; Humans; Intestinal Absorption; Male; Micelles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Solute Carrier Family 22 Member 5; Stearic Acids | 2020 |
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel.
Topics: Acyl-CoA Dehydrogenase; Albumin-Bound Paclitaxel; Albumins; Carnitine; Cell Differentiation; Cell Line, Tumor; Cell Survival; Fatty Acids; Humans; Metabolomics; Neurotoxins; Oxidation-Reduction; Paclitaxel; Solvents | 2021 |
The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
Topics: 3' Untranslated Regions; Carnitine; Cell Line, Tumor; DNA, Complementary; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Signal Transduction; Taxoids; Transforming Growth Factor beta | 2022 |